Pharmaceutical Litigation
FDA Approval Does Not Prevent Pharmaceutical LitigationA drug is released to the market following approval by the Food and Drug Administration (FDA). But, that does not mean the product is safe. At Greg Jones & Associates, we advocate for clients harmed by supposedly harmless drugs in pharmaceutical litigation claims.
When a drug manufacturer markets a harmful product, we hold them accountable for any and all damages to our clients. For help with a complex pharmaceutical litigation case, contact us at 910-338-2629 or toll free at 866-674-5866.
Holding Drug Manufacturers AccountableDrug side effects can be minor. Other times, they can be severe and even deadly. FDA approval does not ensure that you will not be harmed in some way by the medication that should help your medical condition. That is where we come in to help.
At Greg Jones & Associates, our pharmaceutical litigation attorneys have represented clients who have suffered adverse reactions from:
- Digitek Digoxin
- Duragesic
- Chantix
- Heparin
- Trasylol
- Ketek
- Botox
Individual and Class Action Pharmaceutical LitigationOur practice of pharmaceutical litigation includes class action, individual and multidistrict litigation (MDL). Regardless of the complexity of your case, we are not quick to accept the first offer from a defendant just to avoid a lawsuit. Other firms may tout their ability to settle. We tout our ability to litigate and back up that claim with a department devoted solely to litigation.
Contact UsWe serve clients throughout North Carolina and South Carolina with offices in Myrtle Beach, Wilmington, Lumberton, Elizabethtown, Shallotte, Laurinburg, Whiteville, and Jacksonville. For more information or to schedule an appointment with an experienced pharmaceutical litigation lawyer, please contact us.
